-
Mashup Score: 4Turning tides for endotoxin testing - 2 month(s) ago
The drug industry may finally phase out using horseshoe crab blood. What took so long?
Source: cen.acs.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1R&D for long COVID is collapsing - 4 month(s) ago
Public and private funding is lacking, scrambling opportunities to develop treatments
Source: cen.acs.orgCategories: General Medicine News, Infectious DiseaseTweet-
“Private investors, Big Pharma, and government agencies alike see long COVID as too risky as long as its underlying mechanisms are so poorly understood. This dynamic has hampered the few biotechnology & pharmaceutical companies” https://t.co/CNI1xQtEiV
-
-
Mashup Score: 1Sickle cell disease in India: The quest for a cure - 5 month(s) ago
Currently approved gene therapies are out of reach, but research efforts in the country offer a glimmer of hope
Source: cen.acs.orgCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch #genetherapy expert Dr. Jen Adair weighs in on international efforts to make sickle cell treatments more available to people. https://t.co/BhPDASkn98
-
-
Mashup Score: 0Sickle cell disease in India: The quest for a cure - 5 month(s) ago
Currently approved gene therapies are out of reach, but research efforts in the country offer a glimmer of hope
Source: cen.acs.orgCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch #genetherapy expert Dr. Jen Adair weighs in on international efforts to make sickle cell treatments more available to people. https://t.co/BhPDASkn98
-
-
Mashup Score: 2Materials scientist explains why he started commenting on PubPeer - 5 month(s) ago
Angus Wilkinson reflects on his first 6 months as a part-time research sleuth
Source: cen.acs.orgCategories: General Medicine News, Hem/OncsTweet-
Materials scientist explains why he started commenting on @PubPeer: @AngusJWilkinson reflects on his first 6 months as a part-time research sleuth https://t.co/8ouerDMO1D via @DalmeetS
-
-
Mashup Score: 1
It’s difficult enough to make antibiotics for drug-resistant bacteria. What happens when the reward for doing so is bankruptcy?
Source: cen.acs.orgCategories: General Medicine News, General HCPsTweet-
"Is the [#antibiotics] ecosystem dry? Yes. Do we need something to fix it? Yes, urgently,” Frederic Peyrane, a financial consultant @AllianceBEAM told @cenmag. https://t.co/gOJeJy2saa
-
-
Mashup Score: 17Ahmed Badran - 7 month(s) ago
This synthetic biologist evolves proteins to tackle global challenges like climate change
Source: cen.acs.orgCategories: General Medicine News, General NewsTweet-
#ICYMI: @AhmedHBadran is named one of @cenmag’s “Talented 12”! Recognized for his pioneering work in #biologicalengineering, Badran is developing innovative solutions for #climatechange and #healthcare. Read more at: https://t.co/3e5jzjimkL
-
-
Mashup Score: 71Boldly going where no C–H activation has gone before - 7 month(s) ago
Chiral catalyst reaches remote bonds on cyclic compounds
Source: cen.acs.orgCategories: General Medicine News, General HCPsTweet-
#ICYMI: The Yu Lab is featured in @cenmag for developing a new set of copper-catalyzed organic synthesis reactions for building and modifying pharmaceuticals and other molecules which are expected to be widely used in drug discovery and optimization. https://t.co/i6kzNhEtjR
-
-
Mashup Score: 5
The drug discovery firm lifts the lid on how it designed INS018_055, now in Phase 2 clinical trials
Source: cen.acs.orgCategories: General Medicine News, Future of MedicineTweet-
@InSilicoMeds @biogerontology Insilico reveals a ‘soup to nuts’ process for AI-generated lung fibrosis drug #NBTintheNews via @cenmag https://t.co/tjKb7qegLt
-
-
Mashup Score: 1C&EN’s 10 Start-Ups to Watch for 2023 - 1 year(s) ago
Aiming for impact through entrepreneurship
Source: cen.acs.orgCategories: General Medicine News, General NewsTweet-
Congrats to Belharra Therapeutics for being named one of @C&EN's top 10 start-ups to watch! Co-founded by Scripps Research scientists Chris Parker, John Teijaro, and Ben Cravatt, Belharra is targeting proteins that a drug has never targeted before. https://t.co/D66S4eLjBV
-
“Any injected drug or implanted device is tested for endotoxins..Horseshoe crab blood contains a sensitive biosensor system that pharmaceutical companies use to detect those glycolipids.” https://t.co/c1nz6K6yEO